1.1 Introduction
Malaria is a mosquito-borne infectious disease caused by Plasmodium parasites, transmitted to humans primarily through the bite of infected female Anopheles mosquitoes. It is characterized by fever, chills, anemia, and in severe cases, cerebral complications and death (World Health Organization, 2021). In pregnancy, malaria is particularly concerning because it compromises maternal immunity and affects fetal development, leading to outcomes such as low birth weight, preterm delivery, and increased perinatal mortality (Rogerson et al., 2018).
HIV, or Human Immunodeficiency Virus, is a retrovirus that attacks the immune system, specifically targeting CD4+ T cells, thereby weakening the body's defense against opportunistic infections (UNAIDS, 2023). HIV infection in pregnancy increases susceptibility to infections, including malaria, and heightens the risk of adverse maternal and neonatal outcomes. Vertical transmission of HIV from mother to child remains a critical concern in antenatal care, particularly when co-infections complicate the maternal health status (Adam et al., 2014).
As a prelude to other parts of this study, this chapter will discuss the background upon which this study was initiated, the statement of problems that led to this study, the Aim and Objectives of the study. Others are significance of the study, scope of work, research hypothesis and questions, limitation of the study and definition of terms.
1.2 Background of Study
Malaria has been recognized as a major public health challenge for centuries, with evidence of the disease dating back to ancient civilizations. According to Greenwood, malaria was prevalent in many parts of Africa long before colonial records, and early communities developed traditional strategies to mitigate its impact, including the use of herbal remedies and environmental management. The introduction of quinine in the 17th century marked the beginning of scientific approaches to malaria treatment and prevention. In Nigeria, malaria became more formally documented during the colonial period, when British health officials reported high morbidity and mortality rates, particularly among pregnant women and children (Greenwood, 2016).
Malaria and Human Immunodeficiency Virus (HIV) infections remain major public health problems worldwide, particularly in sub-Saharan Africa where the burden of both diseases is highest. According to the World Health Organization (2021), malaria is a life-threatening parasitic disease transmitted by Anopheles mosquitoes and remains one of the leading causes of morbidity and mortality among pregnant women and children under five in endemic regions.
Chukwuocha reported that pregnancy alters immune responses, making pregnant women more susceptible to malaria infection and its complications, including severe anaemia and placental parasitaemia, which contribute significantly to adverse maternal and fetal outcomes (Chukwuocha et al., 2018). According to Mokuolu, malaria infection during pregnancy is among the principal causes of low birth weight, intrauterine growth restriction, preterm delivery, and increased neonatal mortality. When these outcomes occur, they represent not only individual health crises but also systemic public health challenges that strain health services and contribute to long-term socio-economic impacts (Mokuolu et al., 2016).
HIV infection further complicates this picture because it weakens the immune system and predisposes individuals to opportunistic infections, including more frequent and severe episodes of malaria. According to UNAIDS (2023), an estimated 38.4 million people were living with HIV globally at the end of 2022, with sub-Saharan Africa accounting for a disproportionate share of cases. HIV remains a critical concern among pregnant women as it increases the risk of mother-to-child transmission, undermines maternal health, and poses challenges for effective antenatal care delivery.
According to Malhotra, HIV infection has been shown to modify the clinical course of malaria by increasing parasite density and reducing the efficacy of malaria immunity, resulting in more severe clinical manifestations and increased complications during pregnancy (Malhotra et al., 2019). This interaction underscores a synergistic relationship between the two infections, where each disease worsens the impact of the other. In this context, the co-infection of malaria and HIV is not merely the coexistence of two diseases but a complex interplay that influences disease progression, immune response, and clinical outcomes.
In Nigeria, malaria is endemic, occurring year-round with higher transmission during the rainy season. According to the National Malaria Elimination Programme (2020), malaria accounts for over 60% of outpatient visits and 30% of hospital admissions annually, with pregnant women among the most affected groups. The Nigerian Demographic and Health Survey also indicate that malaria prevalence remains high among women of reproductive age, particularly those accessing public health facilities for antenatal services. The burden of malaria in pregnancy has direct implications for maternal health, as it increases the risk of maternal anaemia, stillbirth, and neonatal death.
This study is set against the backdrop of persistent high burdens of malaria and HIV infections among pregnant women, challenges in integrated antenatal care delivery, and the need to generate context-specific evidence to guide effective interventions.
1.3 Statement of Problems
Investigation revealed that pregnancy is a period of increased vulnerability to infectious diseases, especially malaria and HIV, which remain leading causes of morbidity and mortality among pregnant women in sub-Saharan Africa including Nigeria (Rogerson et al., 2018). Malaria infection during pregnancy is associated with severe anaemia, low birth weight, preterm delivery, and increased risk of infant mortality (Dellicour et al., 2010). HIV infection weakens the immune system and increases susceptibility to opportunistic infections including malaria (WHO, 2021).
In Nigeria, malaria is endemic and accounts for a significant proportion of outpatient visits and hospital admissions, with pregnant women bearing a substantial share of the disease burden (NMEP, 2020). The prevalence of HIV among pregnant women in Nigeria also remains a public health concern; the infection affects maternal health and contributes to vertical transmission to infants (UNAIDS, 2023).
Furthermore, the presence of malaria parasitaemia may reduce the efficacy of antiretroviral therapy and hinder immune recovery in HIV-positive pregnant women using antiretroviral drugs, elevating the risk of adverse pregnancy outcomes (Adam et al., 2014). On the other hand, HIV infection is associated with higher malaria parasite densities and more frequent clinical episodes, which heightens maternal anaemia and increases perinatal mortality (van Eijk et al., 2015). It is against this backdrop that this study seeks to investigate the prevalence, determinants, and clinical implications of malaria and HIV co-infection among pregnant women attending antenatal clinics at Olabisi Onabanjo University Teaching Hospital.
1.4 Aim and Objectives of Study
The aim of this study is to analyze the prevalence, determinants, and clinical impact of malaria and HIV co-infection among pregnant women attending antenatal clinics at Olabisi Onabanjo University Teaching Hospital.
The specific objectives of this study include:
- To determine the prevalence of malaria and HIV co-infection among pregnant women attending antenatal clinics at Olabisi Onabanjo University Teaching Hospital.
- To identify the socio-demographic and clinical factors associated with malaria and HIV co-infection in pregnant women.
- To assess the effectiveness of existing preventive and treatment measures, including antiretroviral therapy, intermittent preventive treatment for malaria in pregnancy, and the use of insecticide-treated nets.
- To evaluate the impact of malaria and HIV co-infection on maternal and fetal health outcomes, including anemia, low birth weight, preterm delivery, and vertical transmission of HIV.
- To identify gaps in the existing antenatal care system regarding the management of co-infected patients and recommend strategies for improved integrated care.
1.5 Research Questions
Based on the stated objectives, the study will address the following research questions:
- What is the prevalence of malaria and HIV co-infection among pregnant women attending antenatal clinics at Olabisi Onabanjo University Teaching Hospital?
- What socio-demographic and clinical factors are associated with malaria and HIV co-infection in pregnant women at the hospital?
- How effective are the existing preventive and treatment measures, including antiretroviral therapy, intermittent preventive treatment for malaria in pregnancy, and insecticide-treated nets, in managing co-infected pregnant women?
- What is the impact of malaria and HIV co-infection on maternal and fetal health outcomes, such as anemia, low birth weight, preterm delivery, and vertical HIV transmission?
- What gaps exist in the current antenatal care system regarding the management of co-infected patients, and how can these be addressed to improve integrated care?
1.6 Research Hypotheses
In order to pursue the objective of this study, the following generalized statements have been designed to guide and aids in obtaining the result for the experiment to be conducted. For this work, the null hypothesis will be represented with H0 while the alternative hypothesis will be represented with hypothesis H1.
Hypothesis 1
- H0: There is no significant prevalence of malaria and HIV co-infection among pregnant women attending antenatal clinics at Olabisi Onabanjo University Teaching Hospital.
- H1: There is a significant prevalence of malaria and HIV co-infection among pregnant women attending antenatal clinics at Olabisi Onabanjo University Teaching Hospital.
Hypothesis 2
- H0: Socio-demographic and clinical factors such as age, parity, educational level, and occupation have no significant association with malaria and HIV co-infection in pregnant women.
- H1: Socio-demographic and clinical factors such as age, parity, educational level, and occupation have a significant association with malaria and HIV co-infection in pregnant women.
Hypothesis 3
- H0: Existing preventive and treatment measures, including antiretroviral therapy, intermittent preventive treatment for malaria, and insecticide-treated nets, have no significant effect on managing malaria and HIV co-infection among pregnant women.
- H1: Existing preventive and treatment measures, including antiretroviral therapy, intermittent preventive treatment for malaria, and insecticide-treated nets, have a significant effect on managing malaria and HIV co-infection among pregnant women.
Hypothesis 4
- H0: Malaria and HIV co-infection has no significant impact on maternal and fetal health outcomes, including anemia, low birth weight, preterm delivery, and vertical HIV transmission.
- H1: Malaria and HIV co-infection has a significant impact on maternal and fetal health outcomes, including anemia, low birth weight, preterm delivery, and vertical HIV transmission.
Hypothesis 5
- H0: There are no significant gaps in the existing antenatal care system regarding the management of co-infected patients.
- H1: There are significant gaps in the existing antenatal care system regarding the management of co-infected patients.
1.7 Significance of Study
It is believed that at the completion of the study, reliable data on the prevalence of malaria and HIV co-infection among pregnant women will be available, which will assist the hospital in planning and implementing targeted interventions. The study will also educate pregnant women attending antenatal clinics on the risks, prevention, and management of malaria and HIV co-infection, which will improve adherence to preventive measures such as insecticide-treated nets, intermittent preventive treatment for malaria, and antiretroviral therapy.
Furthermore, the study will enable healthcare providers, including doctors, nurses, and laboratory staff, to identify high-risk patients and improve clinical decision-making, treatment adherence, and monitoring of co-infected pregnant women.
Lastly, the findings will support hospital management and policymakers in designing evidence-based protocols that will reduce maternal anemia, low birth weight, preterm delivery, and vertical transmission of HIV, ultimately improving maternal and neonatal health outcomes.
1.8 Scope of Study
This study focuses on the analysis of malaria and HIV co-infection among pregnant women attending antenatal clinics at Olabisi Onabanjo University Teaching Hospital, Ogun State, Nigeria. The research is limited to women enrolled in the hospital's antenatal care program during the study period and examines their socio-demographic characteristics, clinical profiles, and health outcomes related to co-infection.
1.9 Limitations of the Study
During the course of this study, there were some problems encountered which stood as limitations to the research work. Some of the limitations include:
- Time Constraint: The time frame given to accomplish this project was very short due to school academic calendar and it was carried out under pressure which made the researcher not to implement some necessary features.
- Financial Constraint: Insufficient fund tends to impede the efficiency of the researcher in sourcing for the relevant materials, literature or information and in the process of data collection (internet, questionnaire and interview).
- Initial Cooperation Delay from Respondents: A particular limitation of this work came as a result of the respondent refusal to offer their cooperation at the initial time they were contacted. This contributed in making the success of this research study difficult.
1.10 Definition of Terms
Malaria:
Malaria is a life-threatening parasitic disease caused by Plasmodium species and transmitted to humans through the bite of infected female Anopheles mosquitoes. It is characterized by fever, chills, headache, and anemia, and it poses serious risks to pregnant women and their unborn children (World Health Organization, 2021).
HIV (Human Immunodeficiency Virus):
HIV is a viral infection that attacks the body's immune system, specifically the CD4 cells, reducing the body's ability to fight infections and diseases. If untreated, it can progress to Acquired Immunodeficiency Syndrome (AIDS) (Barre-Sinoussi et al., 2018).
Co-Infection:
Co-infection refers to the simultaneous infection of a single individual by two or more pathogens. In this study, it specifically refers to pregnant women being infected with both malaria and HIV at the same time, which increases the risk of adverse maternal and fetal outcomes (Uneke, 2007).
Antenatal Clinic (ANC):
An antenatal clinic is a specialized healthcare facility where pregnant women receive routine medical care, monitoring, and counseling throughout their pregnancy to ensure maternal and fetal health (Falade et al., 2007).
Prevalence:
Prevalence refers to the proportion of individuals in a population who are affected by a particular disease at a specific point in time or over a defined period. In this study, it refers to the proportion of pregnant women attending antenatal clinics at Olabisi Onabanjo University Teaching Hospital who are co-infected with malaria and HIV (Greenwood, 2016).
…